Læknablaðið - 15.12.1992, Blaðsíða 19

LÆKNABLAÐIÐ
409
2. Wallace RJ, Musher DM. In honour of Dr. Sarah
Branham, a star is bom. Chest 1986; 90: 447-50.
3. Berk SL. From Micrococcus to Moraxella. The
reemergence of Branliamella catarrhalis. Arch Int
Med; 150; 2254-7.
4. Wright PW, Wallace RJ. Pneumonia due to Moraxella
(Branhamella) catarrhalis. Semin Respir Infect 1989;
4: 40-6.
5. DiGiovanni C, Riley TV, Hayne GF, Yeo R, Cooksey
P. Respiratory tract infections due to Brahnamella
catarrhalis; epidemiological data from Westem
Australia Epidemiol Infect 1987; 99: 445-53.
6. Pollard JA, Wallace RJ, Nash DR, Lunan JI, Wilson
RW. Incidence of Branhamella catarrhalis in the
sputa of patients with chronic lung disease. Dmgs
1986; Suppl.3: 103-8.
7. Van Hare GF, Shurin PA, Merchant DC, et al. Acute
otitis media caused by Branhamella catarrhalis;
biology and therapy. Rev Infect Dis 1987; 9; 16-27.
8. Erlendsdóttir H, Thoroddsen E, Stefánsson S,
Gottfreðsson M, Briem H, Guðmundsson S.
Skútabólga-orsakir og forspárgildi nefræktana.
Læknablaðið 1990; 76: 483-7.
9. Lundgren K, Ingvarsson L. Acute otitis media in
Sweden. Role of Branhamella catarrhalis and the
rationale for choice of antimicrobal therapy. Dmgs
1986; 31/SuppI.3: 125-31.
10. Suzuki K, Baba S, Inagaki M, Kobayashi T.
The antibiotic susceptibilities and beta-lactamase
production of clinical isolates of Branhamella
catarrhalis from acute otitis media in children. Auris
Nasus Larynx 1988; 1: 105-11
11. Doem GV, Miller MJ, Winn RE. Branhamella
(Neisseria) catarrhalis systemic disease in humans.
Arch Intem Med 1981; 141: 1690-2.
12. Pfister LE, Gallagher MV, Patterfield TG. Neisseria
catarrhalis bacteremia with endocarditis. JAMA
1965; 193: 399-401.
13. Doem GV, Gantz NM. Isolation of Branhamella
(Neisseria) calarrhalis systemic disease in humans.
Sex Transm Dis 1982; 9: 202-4.
14. Kawakami Y, Segawa K, Kandi M. A case of
acute catarrhal conjunctivitis due to Branhamella
catarrhalis. Microbiol Immunol 1983; 27: 641-3.
15. Craig DB, Wehrle PA. Branhamella catarrhalis septic
arthritis. J Rheumatol 1983; 10: 985-6.
16. Davies BI, Maesen FP. The epidemology of
respiratory tract pathogens in southem Netherlands.
Eur Respir J 1988; 1: 415-20.
17. Murray PR, Washington JA. Microscopic and
bacteriologic analysis of expectorated sputum. Mayo
Clinic Proc 1975; 50; 339-44.
18. Tebbutt GM, Coleman DJ. Evaluation of some
methods for the Iaboratory examination of sputum.
J Clin Pathol 1978; 31: 724-9.
19. Lentino JR, Lucks DA. Non value of sputum
culture in the management of lower respiratory tract
infections. J Clin Microbiol 1987; 25: 758-62.
20. Kristinsson KG. Barkaástunga - Aðferð til greiningar
á neðri loftvegasýkingum. Læknaneminn 1980; 33:
5-8.
21. Guðbjömsson B, Þorsteinsson SB, Kristinsson KG, et
al. Lungnabólga: Orsakir og gildi greiningaraðferða.
Læknablaðið 1987; 73: 359-63.
22. Haraldsson A, Kolbeinsson ÞB, Einarsson EÞ.
Friis-Möller A, Rechnitzer C, Briem H. Orsakir
lungnabólgu á Borgarspítalanum 1. desember 1983
til 30. nóvember 1984. Læknablaðið 1989; 75: 57-61.
23. Carr B, Walsh JB, Coakley D, Scott T, Mulvihill E,
Keane C. Effect of age on adherence of Branhamella
catarrhalis to buccal epithelial cells. Gerontology
1989; 35: 127-9.
24. Patterson TF, Patterson JE, Masecar BL, Barden GE,
Hierholzer WJ, Zervos MJ. A nosocomical outbreak
of BranhameUa catarrhalis confirmed by restriction
endonuclease analysis. J Infect Dis 1988; 157: 996-
1001.
25. Vaneechoutte M, Verschraegen G, Claeys G, Weise B,
Van den Abeele AM. Respiratory tract carrier rates
of Moraxella (Branltamella) catarrhalis in adults
and children and interpretation of the isolation of M.
catarrhalis from sputum. J Clin Microbiol 1990; 28:
2674-80.
26. Stenfors LE, Raisanen S. Interaction between
Streptococcus pneumoniae and Branhamella
catarrhalis obtained from double-colonized healthy
nasopharynx and double-infected diseased middle ear
cavity. Scand J Infect Dis 1989; 21: 397-401.
27. Whitby M, Kristinsson KG, Brown M. Assessment of
rapid methods of pneumococcal antigen detection in
routine sputum bacteriology. J Clin Pathol 1985; 38:
341-4.
28. Labia R, Bartholomy M, Le Bunguennec CB, Van
Hoi-Dang AB. Classification of /3-lactamases from
Branhamella catarrhalis in relation to penicillinases
produced by other bacterial species. Drugs 1986;
31/Suppl.3: 40-7.
29. McLeud DT, Ahmed F, Capewell S, Croughan AJ,
Calder MA, Seaton A. Increase in bronchopulmonary
infection due to Branhamella catarrhalis. Br Med J
1986; 292: 1103-5.
30. Farmer T, Reading C. Inhibition of the /3-lactamases
of BranhameUa catarrhalis by clavulanic acid and
other inhibitors. Dmgs 1986; 3 l/Suppl.3: 70-8.
31. Thomley PE, Aitken JM, Nichol GM, Slavin
NJ. Amoxycillin-clavulanic acid combination in
bronchopulmonary infection due to /3-lactamase
producing Branhamella catharrhalis. Preliminary
Report. Dmgs 1986; 31/Suppl.3: 113-4.